Skip to main content
Top
Published in: BMC Oral Health 1/2021

Open Access 01-12-2021 | Research

Stimulated saliva composition in patients with cancer of the head and neck region

Authors: Ulrica Almhöjd, Hulya Cevik-Aras, Niclas Karlsson, Jin Chuncheng, Annica Almståhl

Published in: BMC Oral Health | Issue 1/2021

Login to get access

Abstract

Background

To analyse over time changes in stimulated whole saliva regarding total protein, Immunoglobulin A (IgA), and mucin type O-glycans (mostly MUC5B and MUC7) in head and neck cancer patients.

Methods

29 dentate patients (20 men and 9 women, 59 ± 8 years) treated with curative radiation therapy and chemotherapy for cancer of the head and neck region were included. The stimulated whole salivary secretion rate was determined and saliva collected at four time-points: at pretreatment, and at 6 months, 1 and 2 years post treatment. The total protein concentration was determined spectrophotometrically by using Bicinchoninic Acid assay and Immunoglobulin A (IgA) by using ELISA technique. Glycosylation pattern of salivary mucins was determined in samples collected pre- and post treatment by using LC/MS electrospray and mucin content quantified using SDS-AgPAGE gels and PAS staining.

Results

Compared with pretreatment, the total protein concentration was increased already at 6 months post treatment (p < 0.01), and continued to increase up to 2 years post treatment (p < 0.001). During that period no significant changes in IgA concentration was detected. At pretreatment, the output/min of both total protein and IgA was significantly higher than at all time-points post treatment. Saliva from the cancer patients showed a low abundance/no detectable MUC7, while the MUC5B level remained, compared to saliva from a healthy control. The glycomic analysis showed that the percentage of core 2 O-glycans was increased as core 1, 3 and 4 O-glycans were decreased. The level of sialylation was higher at 6 months post treatment, while sulfation was lower.

Conclusion

A decreased output per minute of proteins at decreased salivary secretion rate, as well as reduced sulfation of MUC5B at 6 months post treatment tended to correlate with the patients’ experience of sticky saliva and oral dryness. At 2 years post treatment, the decreased amount of IgA combined with a lowered salivary secretion rate indicate a reduced oral defense with increased risk of oral infections.
Literature
1.
go back to reference Proctor GB. The physiology of salivary secretion. Peridontology. 2000;2016(70):11–25. Proctor GB. The physiology of salivary secretion. Peridontology. 2000;2016(70):11–25.
2.
go back to reference Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics. 2005;5:1714–28.PubMedCrossRef Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics. 2005;5:1714–28.PubMedCrossRef
3.
go back to reference Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016;8:44.PubMedPubMedCentralCrossRef Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016;8:44.PubMedPubMedCentralCrossRef
4.
go back to reference Carpenter GH. The secretion, components, and properties of saliva. Ann Rev Food Sci Technol. 2013;4:267–76.CrossRef Carpenter GH. The secretion, components, and properties of saliva. Ann Rev Food Sci Technol. 2013;4:267–76.CrossRef
5.
go back to reference Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosth Dent. 1994;85:162–9.CrossRef Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosth Dent. 1994;85:162–9.CrossRef
6.
go back to reference Lynge Pedersen AM, Belstrøm D. The role of natural salivary defenses in maintaining a healthy oral microbiota. J Dent. 2019;80:S3–12.PubMedCrossRef Lynge Pedersen AM, Belstrøm D. The role of natural salivary defenses in maintaining a healthy oral microbiota. J Dent. 2019;80:S3–12.PubMedCrossRef
7.
go back to reference Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol. 2001;61:271–4.PubMedCrossRef Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol. 2001;61:271–4.PubMedCrossRef
8.
go back to reference Almståhl A, Finizia C, Carlén A, Fagerberg-Mohlin B, Alstad T. Explorative study on mucosal and major salivary secretion rates, caries and plaque microflora in head and neck cancer patients. Int J Dent Hyg. 2018;16:450–8.PubMedCrossRef Almståhl A, Finizia C, Carlén A, Fagerberg-Mohlin B, Alstad T. Explorative study on mucosal and major salivary secretion rates, caries and plaque microflora in head and neck cancer patients. Int J Dent Hyg. 2018;16:450–8.PubMedCrossRef
9.
go back to reference Almståhl A, Wikström M, Fagerberg-Mohlin B. Microflora in oral ecosystems up to 3 years after radiation therapy in the head and neck region. Arch Oral Biol. 2015;60:1187–95.PubMedCrossRef Almståhl A, Wikström M, Fagerberg-Mohlin B. Microflora in oral ecosystems up to 3 years after radiation therapy in the head and neck region. Arch Oral Biol. 2015;60:1187–95.PubMedCrossRef
10.
go back to reference Richards TM, Hurley T, Grove L, Harrington KJ, Carpenter GH, Proctor GB, et al. The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral Dis. 2017;23:990–1000.PubMedPubMedCentralCrossRef Richards TM, Hurley T, Grove L, Harrington KJ, Carpenter GH, Proctor GB, et al. The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral Dis. 2017;23:990–1000.PubMedPubMedCentralCrossRef
11.
go back to reference Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613–7.PubMedCrossRef Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613–7.PubMedCrossRef
12.
go back to reference Jasim HH. Effects of X-radiation on the salivary composition. Eur J Pharm Med Res. 2017;4:110–4. Jasim HH. Effects of X-radiation on the salivary composition. Eur J Pharm Med Res. 2017;4:110–4.
13.
go back to reference Eliasson L, Almståhl A, Lingström P, Wikström M, Carlén A. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjögren’s syndrome and radiation therapy. Arch Oral Biol. 2005;50:293–9.PubMedCrossRef Eliasson L, Almståhl A, Lingström P, Wikström M, Carlén A. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjögren’s syndrome and radiation therapy. Arch Oral Biol. 2005;50:293–9.PubMedCrossRef
14.
go back to reference Ajila V, Shetty V, Babu S, Hegde S, Rao S. Immunoglobulin A in oral potentially malignant disorders and oral squamous cell carcinoma. J Med Sci. 2017;37:195–200.CrossRef Ajila V, Shetty V, Babu S, Hegde S, Rao S. Immunoglobulin A in oral potentially malignant disorders and oral squamous cell carcinoma. J Med Sci. 2017;37:195–200.CrossRef
15.
go back to reference Frenkel ES, Ribbeck K. Salivary mucins in host defense and disease prevention. J Oral Microbiol. 2015;7:29759.PubMedCrossRef Frenkel ES, Ribbeck K. Salivary mucins in host defense and disease prevention. J Oral Microbiol. 2015;7:29759.PubMedCrossRef
16.
go back to reference Tribius S, Raguse M, Voigt C, Münscher A, Gröbe A, Petersen C, et al. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer. Strahlenther Onkol. 2015;191:501–10.PubMedCrossRef Tribius S, Raguse M, Voigt C, Münscher A, Gröbe A, Petersen C, et al. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer. Strahlenther Onkol. 2015;191:501–10.PubMedCrossRef
17.
go back to reference Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C. Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg. 2019;17:46–54.PubMedCrossRef Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C. Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg. 2019;17:46–54.PubMedCrossRef
18.
go back to reference Almståhl A, Wikström M, Groenink J. Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins. Oral Microbiol Immunol. 2001;16:345–52.PubMedCrossRef Almståhl A, Wikström M, Groenink J. Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins. Oral Microbiol Immunol. 2001;16:345–52.PubMedCrossRef
19.
go back to reference Almståhl A, Finizia C, Carlén A, Fagerberg-Mohlin B, Alstad T. Mucosal microflora in head and neck cancer patients. Int J Dent Hyg. 2018;16:459–66.PubMedCrossRef Almståhl A, Finizia C, Carlén A, Fagerberg-Mohlin B, Alstad T. Mucosal microflora in head and neck cancer patients. Int J Dent Hyg. 2018;16:459–66.PubMedCrossRef
20.
go back to reference Schulz BJ, Packer NH, Karlsson NG. Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. Anal Chem. 2002;74:6088–97.PubMedCrossRef Schulz BJ, Packer NH, Karlsson NG. Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. Anal Chem. 2002;74:6088–97.PubMedCrossRef
21.
go back to reference Hayes CA, Karlsson NG, Struwe WB, Lisacek F, Rudd PM, Packer NH, et al. UniCarb-DB: a database resource for glycomic discovery. Bioinformatics. 2011;27:1343–4.PubMedCrossRef Hayes CA, Karlsson NG, Struwe WB, Lisacek F, Rudd PM, Packer NH, et al. UniCarb-DB: a database resource for glycomic discovery. Bioinformatics. 2011;27:1343–4.PubMedCrossRef
22.
go back to reference Walz A, Stühler K, Wattenberg A, Hawranke E, Meyer HE, Schmalz G, et al. Proteome analysis of glandular parotid and submandibular-sublingual saliva in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics. 2006;6:1631–9.PubMedCrossRef Walz A, Stühler K, Wattenberg A, Hawranke E, Meyer HE, Schmalz G, et al. Proteome analysis of glandular parotid and submandibular-sublingual saliva in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics. 2006;6:1631–9.PubMedCrossRef
23.
go back to reference Nagler RM. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis. 2002;8:141–6.PubMedCrossRef Nagler RM. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis. 2002;8:141–6.PubMedCrossRef
24.
go back to reference Kashima HK, Kirkham WR, Andrews JR. Postirradiation sialadenitis: a study of the clinical features histopathologic changes and serum enzyme variations following irradiation of human salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1965;94:271–91. Kashima HK, Kirkham WR, Andrews JR. Postirradiation sialadenitis: a study of the clinical features histopathologic changes and serum enzyme variations following irradiation of human salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1965;94:271–91.
25.
go back to reference Baum BJ, Bodner L, Fox PC, Izutsu KT, Pizzo PA, Wright WE. Therapy induced dysfunction of salivary glands: Implications for oral health. Spec Care Dent. 1985;5:274–5.CrossRef Baum BJ, Bodner L, Fox PC, Izutsu KT, Pizzo PA, Wright WE. Therapy induced dysfunction of salivary glands: Implications for oral health. Spec Care Dent. 1985;5:274–5.CrossRef
26.
go back to reference Eliasson L, Birkhed D, Österberg T, Carlén A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci. 2006;114:494–9.PubMedCrossRef Eliasson L, Birkhed D, Österberg T, Carlén A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci. 2006;114:494–9.PubMedCrossRef
27.
go back to reference Dijkema T, Terhaard CHJ, Roesink JM, Raaijmakers CPJ, van den Keijbus PAM, Brand HS, et al. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head and neck cancer: a pilot study. Radiat Oncol. 2012;7:91.PubMedPubMedCentralCrossRef Dijkema T, Terhaard CHJ, Roesink JM, Raaijmakers CPJ, van den Keijbus PAM, Brand HS, et al. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head and neck cancer: a pilot study. Radiat Oncol. 2012;7:91.PubMedPubMedCentralCrossRef
28.
go back to reference Rayment SA, Liu B, Offner GD, Oppenheim FG, Troxler RF. Immunoquantification of human salivary mucins MG1 and MG2 in stimulated whole saliva: factors influencing mucin levels. J Dent Res. 2000;79:1765–72.PubMedCrossRef Rayment SA, Liu B, Offner GD, Oppenheim FG, Troxler RF. Immunoquantification of human salivary mucins MG1 and MG2 in stimulated whole saliva: factors influencing mucin levels. J Dent Res. 2000;79:1765–72.PubMedCrossRef
29.
go back to reference Crouzier T, Boettcher K, Geonnotti AR, Kavanaugh NL, Hirsch JB, Ribbeck K, Lieleg O. Modulating mucin hydration and lubrication by deglycosylation and polyethylene glycol binding. Adv Mater Interfaces. 2015;2:1500308.CrossRef Crouzier T, Boettcher K, Geonnotti AR, Kavanaugh NL, Hirsch JB, Ribbeck K, Lieleg O. Modulating mucin hydration and lubrication by deglycosylation and polyethylene glycol binding. Adv Mater Interfaces. 2015;2:1500308.CrossRef
30.
go back to reference Everest-Dass AV, Jin D, Thaysen-Andersen M, Nevalainen H, Kolarich D, Packer NH. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology. 2012;22:1465–79.PubMedCrossRef Everest-Dass AV, Jin D, Thaysen-Andersen M, Nevalainen H, Kolarich D, Packer NH. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology. 2012;22:1465–79.PubMedCrossRef
31.
go back to reference Alliende C, Kwon Y-L, Brito M, Molina C, Aguilera S, Perez P, et al. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis. 2008;67:1480–7.PubMedCrossRef Alliende C, Kwon Y-L, Brito M, Molina C, Aguilera S, Perez P, et al. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis. 2008;67:1480–7.PubMedCrossRef
32.
go back to reference Bolscher J, Veerman E, Nieuw Amerongen AV, Tulp A, Verwoerd D. Distinct population of high-Mr mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis. Biochem J. 1995;309:801–6.PubMedPubMedCentralCrossRef Bolscher J, Veerman E, Nieuw Amerongen AV, Tulp A, Verwoerd D. Distinct population of high-Mr mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis. Biochem J. 1995;309:801–6.PubMedPubMedCentralCrossRef
33.
go back to reference Chaudbury NMA, Shirlaw P, Pramanik R, Carpenter GH, Proctor GB. Changes in saliva rheological properties and mucin glycosylation in dry mouth. J Dent Res. 2015;94:1660–7.CrossRef Chaudbury NMA, Shirlaw P, Pramanik R, Carpenter GH, Proctor GB. Changes in saliva rheological properties and mucin glycosylation in dry mouth. J Dent Res. 2015;94:1660–7.CrossRef
34.
36.
go back to reference Chaudbury NMA, Proctor GB, Karlsson NG, Carpenter GH, Flowers SA. Reduced mucin-7 (Muc7) sialylation and altered saliva rheology in Sjögren’s syndrome associated oral dryness. Molec Cell Prot. 2016;15:1048–59.CrossRef Chaudbury NMA, Proctor GB, Karlsson NG, Carpenter GH, Flowers SA. Reduced mucin-7 (Muc7) sialylation and altered saliva rheology in Sjögren’s syndrome associated oral dryness. Molec Cell Prot. 2016;15:1048–59.CrossRef
37.
go back to reference Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. Unpacking of a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol. 2010;298:L15–22.PubMedCrossRef Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. Unpacking of a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol. 2010;298:L15–22.PubMedCrossRef
38.
go back to reference Paz HB, Tisdale AS, Danjo Y, Spurr-Michaud SJ, Argüeso P, Gipson IK. The role of calcium in mucin packaging within goblet cells. Exp Eye Res. 2003;77:69–75.PubMedCrossRef Paz HB, Tisdale AS, Danjo Y, Spurr-Michaud SJ, Argüeso P, Gipson IK. The role of calcium in mucin packaging within goblet cells. Exp Eye Res. 2003;77:69–75.PubMedCrossRef
39.
go back to reference Chen EYT, Yang N, Quinton PM, Chin W-C. A new role for bicarbonate in mucus formation. Am J Physiol Lunc Cell Mol Physiol. 2010;299:L542–9.CrossRef Chen EYT, Yang N, Quinton PM, Chin W-C. A new role for bicarbonate in mucus formation. Am J Physiol Lunc Cell Mol Physiol. 2010;299:L542–9.CrossRef
40.
go back to reference Hughes GW, Ridley C, Collins R, Roseman A, Ford R, Thornton DJ. The MUC5B mucin polymer is dominated by repeating structural motifs and its topology is regulated by calcium and pH. Sci Rep. 2019;9:17350.PubMedPubMedCentralCrossRef Hughes GW, Ridley C, Collins R, Roseman A, Ford R, Thornton DJ. The MUC5B mucin polymer is dominated by repeating structural motifs and its topology is regulated by calcium and pH. Sci Rep. 2019;9:17350.PubMedPubMedCentralCrossRef
41.
go back to reference Almståhl A, Wikström M. Electrolytes in stimulated whole saliva at hyposalivation of different origins. Arch Oral Biol. 2003;48:337–44.PubMedCrossRef Almståhl A, Wikström M. Electrolytes in stimulated whole saliva at hyposalivation of different origins. Arch Oral Biol. 2003;48:337–44.PubMedCrossRef
42.
go back to reference Sim CPC, Soong YL, Pang EPP, Lim C, Walker GD, Manton DJ, et al. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up. Aust Dent J. 2018;63:217–23.PubMedCrossRef Sim CPC, Soong YL, Pang EPP, Lim C, Walker GD, Manton DJ, et al. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up. Aust Dent J. 2018;63:217–23.PubMedCrossRef
43.
go back to reference Mossman KL, Shatzman AR, Chencharick JD. Effects of radiotherapy on human parotid saliva. Radiat Res. 1981;88:403–12.PubMedCrossRef Mossman KL, Shatzman AR, Chencharick JD. Effects of radiotherapy on human parotid saliva. Radiat Res. 1981;88:403–12.PubMedCrossRef
Metadata
Title
Stimulated saliva composition in patients with cancer of the head and neck region
Authors
Ulrica Almhöjd
Hulya Cevik-Aras
Niclas Karlsson
Jin Chuncheng
Annica Almståhl
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2021
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-021-01872-x

Other articles of this Issue 1/2021

BMC Oral Health 1/2021 Go to the issue